White label ELPA - ClinicalTrials.eu

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Not recruiting

2 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Investigated drugs:
- Mbs2320
Study on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma

Not recruiting

3 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Tezepelumab
Study on Sentinel Node Detection Using Technetium-99m and Indocyanine Green in Patients with Early-Stage Ovarian Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Ovarian epithelial cancer
Investigated drugs:
Study of Methylone Treatment for Adults with Post-Traumatic Stress Disorder (PTSD)

Not recruiting

1 1
Investigated diseases:
- Post-traumatic stress disorder
Investigated drugs:
- Methylone
Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Not recruiting

3 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Pembrolizumab
Study on Apalutamide and Drug Combination for Patients with Metastatic Castration-Sensitive Prostate Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
Study of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone-refractory prostate cancer
- Prostate cancer
Investigated drugs:
Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

Not recruiting

2 1 1 1
Investigated diseases:
- Adrenogenital syndrome
Investigated drugs:
Study on VX-522 and Ivacaftor for Adults with Cystic Fibrosis Unresponsive to CFTR Modulator Therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Cystic fibrosis
Investigated drugs:
- Vx-522
- Ivacaftor

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies